Statements (60)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:advocates_for |
gptkb:Ewing's_Sarcoma_Foundation
|
| gptkbp:affects |
bones
soft tissue |
| gptkbp:associated_with |
chromosomal translocation
|
| gptkbp:clinical_trial |
ongoing
aggressive behavior high metastatic potential |
| gptkbp:end_of_life |
higher in localized cases
lower in metastatic cases |
| gptkbp:events |
necessary
monitoring for recurrence |
| gptkbp:first_described_by |
gptkb:1921
|
| gptkbp:genetic_diversity |
EWS R1 gene
|
| gptkbp:historical_significance |
first identified in the early 20th century
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ewing's Sarcoma
|
| gptkbp:is_involved_in |
available for patients
|
| gptkbp:is_often_used_in |
gptkb:Person
young adults |
| gptkbp:named_after |
gptkb:James_Ewing
|
| gptkbp:number_of_stages |
localized
recurrent metastatic |
| gptkbp:occurs_in |
rare
approximately 1 in 1,000,000 |
| gptkbp:population |
more common in males
more common in Caucasians |
| gptkbp:provides_information_on |
combination therapy
|
| gptkbp:public_awareness |
September
|
| gptkbp:receives_funding_from |
limited
|
| gptkbp:research_focus |
gptkb:vaccine
targeted therapy |
| gptkbp:risk_factor |
family history
genetic syndromes |
| gptkbp:side_effect |
nausea
hair loss infection risk |
| gptkbp:social_responsibility |
biopsy
imaging tests depends on location depends on stage depends on age |
| gptkbp:symptoms |
fatigue
weight loss fever pain swelling |
| gptkbp:team |
involved in treatment
|
| gptkbp:treatment |
gptkb:hospital
variable radiation therapy chemotherapy curative intent specialized cancer center |
| gptkbp:website |
arms
chest wall pelvis legs |
| gptkbp:bfsParent |
gptkb:Oskar_Lindblom
|
| gptkbp:bfsLayer |
4
|